Literature DB >> 7672515

A chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity.

R Ippoliti1, E Lendaro, I D'Agostino, M L Fiani, D Guidarini, S Vestri, P A Benedetti, M Brunori.   

Abstract

Human transferrin (Tf) and saporin-6 (Sap), a ribosome inactivating protein from Saponaria officinalis, were chemically conjugated: the reaction generated two chimeras (called Tf-Sap) that proved to be cytotoxic to HepG2 cells. Electrophoretic and chromatographic analysis revealed that the two conjugates contained saporin and Tf in a 2:1 or 1:1 molar ratio (140 and 110 KDa, respectively). Free saporin is essentially nontoxic, whereas Tf-Sap efficiently kills HepG2 cells, although its ID50 (= 6 nM) is 1000-fold greater than that of ricin. Intracellular transport of these toxins was followed by in vivo fluorescence video microscopy, preparing the conjugates starting from rhodamine isothiocyanate-labeled saporin. Image analysis of living HepG2 cells exposed to fluorescent Tf-Sap revealed that the endocytotic pathway involving passage through secondary endosomes is dictated by Tf and is different from that of ricin (the dimeric toxin from Ricinus communis), which is delivered to the Golgi apparatus, the probable site of activation. We discuss whether differences in toxicity between ricin and Tf-Sap can be attributed to the different mechanisms of transport and activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672515     DOI: 10.1096/fasebj.9.12.7672515

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  14 in total

Review 1.  Subcellular targeting strategies for drug design and delivery.

Authors:  Lawrence Rajendran; Hans-Joachim Knölker; Kai Simons
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

Review 2.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Authors:  Tracy R Daniels; Ezequiel Bernabeu; José A Rodríguez; Shabnum Patel; Maggie Kozman; Diego A Chiappetta; Eggehard Holler; Julia Y Ljubimova; Gustavo Helguera; Manuel L Penichet
Journal:  Biochim Biophys Acta       Date:  2011-08-05

3.  Comparative studies on kinetics of inhibition of protein synthesis in intact cells by ricin and a conjugate of ricin B-chain with momordin.

Authors:  S Sharma; S K Podder; A A Karande
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

4.  Targeted delivery of saporin toxin by monoclonal antibody to the transcobalamin receptor, TCblR/CD320.

Authors:  Edward V Quadros; Yasumi Nakayama; Jeffrey M Sequeira
Journal:  Mol Cancer Ther       Date:  2010-09-21       Impact factor: 6.261

5.  Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity.

Authors:  Hongling Yuan; Quan Du; Matthew B Sturm; Vern L Schramm
Journal:  Biochemistry       Date:  2015-07-14       Impact factor: 3.162

Review 6.  Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.

Authors:  Stephanie Tortorella; Tom C Karagiannis
Journal:  J Membr Biol       Date:  2014-02-27       Impact factor: 1.843

7.  Expression and purification of cysteine introduced recombinant saporin.

Authors:  Emine Günhan; Mimi Swe; Mine Palazoglu; John C Voss; Leo M Chalupa
Journal:  Protein Expr Purif       Date:  2007-11-19       Impact factor: 1.650

Review 8.  Co-opting biology to deliver drugs.

Authors:  Parisa Yousefpour; Ashutosh Chilkoti
Journal:  Biotechnol Bioeng       Date:  2014-07-21       Impact factor: 4.530

Review 9.  Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy.

Authors:  José M Ferreras; Lucía Citores; Rosario Iglesias; Pilar Jiménez; Tomás Girbés
Journal:  Toxins (Basel)       Date:  2011-04-29       Impact factor: 4.546

10.  Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes.

Authors:  Wendian Zhang; Fangqi Peng; Taotao Zhou; Yifei Huang; Li Zhang; Peng Ye; Miao Lu; Guang Yang; Yongkang Gai; Tan Yang; Xiang Ma; Guangya Xiang
Journal:  Int J Nanomedicine       Date:  2015-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.